Sage Journals: Discover world-class research

Retricted access

Research article

First published 2022-9

Real world use of FLT3 inhibitors for treatment of FLT3+ acute myeloid leukemia (AML): A single center,propensity-score matched,retrospective cohort study

Brian G Bazzell, Bernard L Marini, Lydia L Benitez [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2025-8

Evaluation of the Toxicity and Outcomes of the Combination of Midostaurin and CLAG-M in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML): A Multicenter Retrospective Analysis

Ashley Chen, Grace Baek, Kathryn Russell [...]

Annals of Pharmacotherapy

Open access

Review article

First published 2019

Allogeneic transplant for FLT3 - ITD mutated AML: a focus on FLT3 inhibitors before,during,and after transplant

Abdul Hamid Bazarbachi, Rama Al Hamed, Florent Malard [...]

Therapeutic Advances in Hematology

Free access

Research article

First published 2012-7

The STAT5 Inhibitor Pimozide Displays Efficacy in Models of Acute Myelogenous Leukemia Driven by FLT3 Mutations

Erik A. Nelson, Sarah R. Walker, Michael Xiang [...]

Genes & Cancer

Free access

Research article

First published 2021-8

Clinical implication and prognostic significance of FLT3-ITD and ASXL1 mutations in Egyptian AML patients: A single-center study

Huda F. Ebian, Sherin Elshorbagy, Haitham Mohamed [...]

Cancer Biomarkers

Free access

Research article

First published 2010-10

Antileukemic Effects of Novel First- and Second-Generation FLT3 Inhibitors

Ellen Weisberg, Johannes Roesel, Pascal Furet [...]

Genes & Cancer

Retricted access

Case report

First published 2025-10

Midostaurin-Associated acute pancreatitis

Mert Akyildiz, Nebi Cankat Geygel, Esma Hazal Burhan [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2021-7

Gilteritinib administration in a hemodialysis patient

Eris Tollkuci, Tiffany Tran, Rebecca Myers

Journal of Oncology Pharmacy Practice

Free access

Review article

First published 2015-4

Novel agents for the treatment of childhood acute leukemia

Colleen E. Annesley, Patrick Brown

Therapeutic Advances in Hematology

Open access

Review article

First published 2019

Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia

Nicholas J. Short, Hagop Kantarjian, Farhad Ravandi [...]

Therapeutic Advances in Hematology

Search results